nasal PYY3-36

peptide YY3-36 · Nastech Pharmaceutical Company, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for nasal PYY3-36, covering 2008-09-15 to 2008-09-15. Get the full timeline:

Most recent: Clinical Trial Update: A Study of Nasal PYY3-36 and Placebo for Weight Loss in Obese Subjects [Phase 2]